secwatch / observer
8-K filed December 12, 2022, 6:59 PM ET ticker AXR CIK 0000006207
earnings confidence high sentiment positive materiality 0.55

AMREP Q2 fiscal 2023 net income rises to $3.6M, EPS $0.68 vs $0.45

AMREP CORP.

2023-Q2 EPS reported $1.04 revenue$26,856,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMREP CORP. reported Six Months Ended October 31, 2022 results: revenue $ 26,856,000, net income $ 5,533,000, EPS $ 1.04.

Period
Six Months Ended October 31, 2022
Revenue
$ 26,856,000
Net income
$ 5,533,000
EPS
$ 1.04
Result
reported results
Exact text from the filing
Six Months Ended October 31, 2022 2021 Revenues $ 26,856,000 $ 26,098,000 Net income $ 5,533,000 $ 4,963,000 Income per share – basic $ 1.05 $ 0.67 Income per share – diluted $ 1.04 $ 0.67 Weighted average number of common shares outstanding – basic 5,277,000 7,354,000 Weighted average number of common shares outstanding – diluted 5,302,000 7,378,000
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMREP CORP. reported Three Months Ended October 31, 2022 results: revenue $ 16,149,000, net income $ 3,621,000, EPS $ 0.68.

Period
Three Months Ended October 31, 2022
Revenue
$ 16,149,000
Net income
$ 3,621,000
EPS
$ 0.68
Result
reported results
Exact text from the filing
Three Months Ended October 31, 2022 2021 Revenues $ 16,149,000 $ 16,112,000 Net income $ 3,621,000 $ 3,326,000 Income per share – basic $ 0.69 $ 0.45 Income per share – diluted $ 0.68 $ 0.45 Weighted average number of common shares outstanding – basic 5,281,000 7,361,000 Weighted average number of common shares outstanding – diluted 5,307,000 7,383,000
View on SEC.gov

Browse all earnings releases →

AMREP CORP. filing history →

Source: SEC EDGAR
accession 0001104659-22-126301
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.